NON-VIRAL NANOPARTICLE-BASED DELIVERY SYSTEM

Organization: 

McGill University, Quebec, CA

I.P. Brief: 

The present technology is about development of novel nanoparticles for delivery of nucleic acids, drugs and other molecules. These novel nanoparticles can bypass blood-brain-barrier and other physiological barriers, targeting neurodegenerative diseases, like Alzheimer's disease. These nanoparticles can be delivered through non-invasive means such as intranasal or intravenous route of administration.

Keywords: 

Nanomedicine, siRNA therapeutics

Primary Industry: 

Nanomedicine

Full IP Descriptions available on-site.